new oral cancer drugs, Nexavar and Sutent

March 2006

You'll see two new oral cancer drugs, Nexavar and Sutent.

These drugs work similarly to Gleevec (imatinib). They block proteins involved in a tumor's growth and blood supply.

But Nexavar and Sutent target a wider range of proteins.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote